RasGrf1 deficiency delays dging in mice

Aging

Volumn 3, Issue 3, 2011, Pages 262-276

  Borrás, Consuelo ^a   Monleón, Daniel ^b   López Grueso, Raul ^a   Gambini, Juan ^a   Orlando, Leonardo ^c   Pallardó, Federico V ^a   Santos, Eugenio ^d   Viña, José ^a   de Mora, Jaime Font ^c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^d CSIC   (Spain)

Author keywords

GEF; IGF 1; Longevity; Metabolism; Positron emission tomography; Ras

Indexed keywords

GLUCOSE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RASGRF1 PROTEIN, MOUSE; RNA 16S; SIRT1 PROTEIN, MOUSE; SIRTUIN 1; SOMATOMEDIN C;

AGING; ANIMAL; ARTICLE; C57BL MOUSE; CALORIC RESTRICTION; GENETICS; GLYCOGEN LIVER LEVEL; LONGEVITY; MALE; METABOLISM; METABOLOME; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE;

AGING; ANIMALS; BASE SEQUENCE; CALORIC RESTRICTION; GLUCOSE; INSULIN-LIKE GROWTH FACTOR I; LIVER GLYCOGEN; LONGEVITY; MALE; METABOLOME; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; PSYCHOMOTOR PERFORMANCE; RAS-GRF1; RNA, RIBOSOMAL, 16S; SIRTUIN 1;

EID: 80051607865     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100279     Document Type: Article

References (68)

1. Farnsworth CL, Freshney NW, Rosen LB, Ghosh A, Greenberg ME and Feig LA. Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature 1995; 376:524-527.
2. Mattingly RR and Macara IG. Phosphorylation-dependent activation of the Ras-GRF/CDC25Mm exchange factor by muscarinic receptors and G-protein beta gamma subunits. Nature 1996; 382:268-272.
3. Shou C, Wurmser A, Suen KL, Barbacid M, Feig LA and Ling K. Differential response of the Ras exchange factor, Ras-GRF to tyrosine kinase and G protein mediated signals. Oncogene 1995; 10:1887-1893.
4. Santos E and Fernandez-Medarde A. Rasgrf1. UCSD-Nature Molecule Pages 2009 Published online. doi:10.1038/ mp.a002032.01.
5. Brambilla R, Gnesutta N, Minichiello L, White G, Roylance AJ, Herron CE, Ramsey M, Wolfer DP, Cestari V, Rossi-Arnaud C, Grant SG, Chapman PF, Lipp HP, Sturani E and Klein R. A role for the Ras signalling pathway in synaptic transmission and longterm memory. Nature 1997; 390:281-286.
6. Font de Mora J, Esteban LM, Burks DJ, Nunez A, Garces C, Garcia-Barrado MJ, Iglesias-Osma MC, Moratinos J, Ward JM and Santos E. Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. Embo J 2003; 22:3039-3049.
7. Giese KP, Friedman E, Telliez JB, Fedorov NB, Wines M, Feig LA and Silva AJ. Hippocampus-dependent learning and memory is impaired in mice lacking the Ras-guanine-nucleotide releasing factor 1 (Ras-GRF1). Neuropharmacology 2001; 41:791-800.
8. Itier JM, Tremp GL, Leonard JF, Multon MC, Ret G, Schweighoffer F, Tocque B, Bluet-Pajot MT, Cormier V and Dautry F. Imprinted gene in postnatal growth role. Nature 1998; 393:125-126.
9. Fabrizio P, Liou LL, Moy VN, Diaspro A, Valentine JS, Gralla EB and Longo VD. SOD2 functions downstream of Sch9 to extend longevity in yeast. Genetics 2003; 163:35-46.
10. De Benedictis G, Carrieri G, Garasto S, Rose G, Varcasia O, Bonafe M, Franceschi C and Jazwinski SM. Does a retrograde response in human aging and longevity exist? Exp Gerontol 2000; 35:795-801.
11. Fontana L, Partridge L and Longo VD. Extending healthy life span--from yeast to humans. Science 2010; 328:321-326.
12. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E and Miller RA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460:392-395.
13. Wei M, Fabrizio P, Hu J, Ge H, Cheng C, Li L and Longo VD. Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9. PLoS Genet 2008; 4:e13.
14. Henkemeyer M, Rossi DJ, Holmyard DP, Puri MC, Mbamalu G, Harpal K, Shih TS, Jacks T and Pawson T. Vascular system defects and neuronal apoptosis in mice lacking ras GTPaseactivating protein. Nature 1995; 377:695-701.
15. Gomez J, Martinez AC, Fernandez B, Garcia A and Rebollo A. Critical role of Ras in the proliferation and prevention of apoptosis mediated by IL-2. J Immunol 1996; 157:2272-2281.
16. Hall-Jackson CA, Jones T, Eccles NG, Dawson TP, Bond JA, Gescher A and Wynford-Thomas D. Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: a potential therapeutic target. Br J Cancer 1998; 78:641-651.
17. Ferrari G and Greene LA. Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death. EMBO J 1994; 13:5922-5928.
18. Spear N, Estevez AG, Johnson GV, Bredesen DE, Thompson JA and Beckman JS. Enhancement of peroxynitrite-induced apoptosis in PC12 cells by fibroblast growth factor-1 and nerve growth factor requires p21Ras activation and is suppressed by Bcl-2. Arch Biochem Biophys 1998; 356:41-45.
19. Mills EM, Takeda K, Yu ZX, Ferrans V, Katagiri Y, Jiang H, Lavigne MC, Leto TL and Guroff G. Nerve growth factor treatment prevents the increase in superoxide produced by epidermal growth factor in PC12 cells. J Biol Chem 1998; 273: 22165-22168.
20. Wei M, Fabrizio P, Madia F, Hu J, Ge H, Li LM and Longo VD. Tor1/Sch9-regulated carbon source substitution is as effective as calorie restriction in life span extension. PLoS Genet 2009; 5: e1000467.
21. Bluher M, Kahn BB and Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003; 299: 572-574.
22. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A and Kopchick JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 2003; 144:3799-3810.
23. Festing MF and Blackmore DK. Life span of specifiedpathogen- free (MRC category 4) mice and rats. Lab Anim 1971; 5:179-192.
24. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P and Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003; 421:182-187.
25. Rowlatt C, Chesterman FC and Sheriff MU. Lifespan, age changes and tumour incidence in an ageing C57BL mouse colony. Lab Anim 1976; 10:419-442.
26. Storer JB. Longevity and gross pathology at death in 22 inbred mouse strains. J Gerontol 1966; 21:404-409.
27. Yan L, Vatner DE, O'Connor JP, Ivessa A, Ge H, Chen W, Hirotani S, Ishikawa Y, Sadoshima J and Vatner SF. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 2007; 130:247-258.
28. Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV and Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003; 34:546-552.
29. Calleja M, Pena P, Ugalde C, Ferreiro C, Marco R and Garesse R. Mitochondrial DNA remains intact during Drosophila aging, but the levels of mitochondrial transcripts are significantly reduced. J Biol Chem 1993; 268:18891-18897.
30. Crawford DR, Wang Y, Schools GP, Kochheiser J and Davies KJ. Down-regulation of mammalian mitochondrial RNAs during oxidative stress. Free Radic Biol Med 1997; 22:551-559.
31. Kadenbach B, Ramzan R and Vogt S. Degenerative diseases, oxidative stress and cytochrome c oxidase function. Trends Mol Med 2009; 15:139-147.
32. Timiras PS. Physiological basis of aging and geriatrics. 2007: viii, 407
33. Longo VD and Fabrizio P. Regulation of longevity and stress resistance: a molecular strategy conserved from yeast to humans? Cell Mol Life Sci 2002; 59:903-908.
34. Guarente L. Sirtuins as potential targets for metabolic syndrome. Nature 2006; 444: 868-874.
35. Bartke A. Insulin and aging. Cell Cycle 2008; 7: p. 3338-3343.
36. Bartke A. New findings in gene knockout, mutant and transgenic mice. Exp Gerontol 2008; 43:11-14.
37. Bartke A. Impact of reduced insulin-like growth factor- 1/insulin signaling on aging in mammals: novel findings. Aging Cell 2008; 7:285-290.
38. Borras C, Stvolinsky S, Lopez-Grueso R, Fedorova T, Gambini J, Boldyrev A and Vina J. Low in vivo brain glucose consumption and high oxidative stress in accelerated aging. FEBS Lett 2009; 583:2287-2293.
39. Ladiges W, Van Remmen H, Strong R, Ikeno Y, Treuting P, Rabinovitch P and Richardson A. Lifespan extension in genetically modified mice. Aging Cell 2009; 8:346-352.
40. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, Claret M, Al-Qassab H, Carmignac D, Ramadani F, Woods A, Robinson IC, Schuster E, Batterham RL, Kozma SC, Thomas G, Carling D, Okkenhaug K, Thornton JM, Partridge L, Gems D and Withers DJ. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009; 326:140-144.
41. Nadon NL, Strong R, Miller RA, Nelson J, Javors M, Sharp ZD, Peralba JM and Harrison DE. Design of aging intervention studies: the NIA interventions testing program. Age (Dordr) 2008; 30:187-199.
42. Matheu A, Maraver A, Klatt P, Flores I, Garcia-Cao I, Borras C, Flores JM, Vina J, Blasco MA and Serrano M. Delayed ageing through damage protection by the Arf/p53 pathway. Nature 2007; 448:375-379.
43. Tomas-Loba A, Flores I, Fernandez-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borras C, Matheu A, Klatt P, Flores JM, Vina J, Serrano M and Blasco MA. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 2008; 135:609-622.
44. Gill TM, Gahbauer EA, Han L and Allore HG. Trajectories of disability in the last year of life. N Engl J Med 2010; 362:1173-1180.
45. Studenski S, Hayes RP, Leibowitz RQ, Bode R, Lavery L, Walston J, Duncan P and Perera S. Clinical Global Impression of Change in Physical Frailty: development of a measure based on clinical judgment. J Am Geriatr Soc 2004; 52:1560-1566.
46. Plass C, Shibata H, Kalcheva I, Mullins L, Kotelevtseva N, Mullins J, Kato R, Sasaki H, Hirotsune S, Okazaki Y, Held WA, Hayashizaki Y and Chapman VM. Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet 1996; 14:106-109.
47. Clapcott SJ, Peters J, Orban PC, Brambilla R and Graham CF. Two ENU-induced mutations in Rasgrf1 and early mouse growth retardation. Mamm Genome 2003; 14:495-505.
48. Kawahara M and Kono T. Longevity in mice without a father. Hum Reprod 2010; 25:457-461.
49. Jaenisch R. DNA methylation and imprinting: why bother? Trends Genet 1997; 13:323-329.
50. Anderson RM, Barger JL, Edwards MG, Braun KH, O'Connor CE, Prolla TA and Weindruch R. Dynamic regulation of PGC- 1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell 2008; 7:101-111.
51. Longo VD. Linking sirtuins, IGF-I signaling, and starvation. Exp Gerontol 2009; 44:70-74.
52. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z and Puigserver P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. Embo J 2007; 26:1913-1923.
53. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P and Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127: p. 1109-1122.
54. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW and Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004; 429:771-776.
55. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM and Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434:113-118.
56. Feige JN, Lagouge M, Canto C, Strehle A, Houten SM, Milne JC, Lambert PD, Mataki C, Elliott PJ and Auwerx J. Specific SIRT1 activation mimics low energy levels and protects against dietinduced metabolic disorders by enhancing fat oxidation. Cell Metab 2008; 8:347-358.
57. Nakae J, Cao Y, Daitoku H, Fukamizu A, Ogawa W, Yano Y and Hayashi Y. The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J Clin Invest 2006; 116:2473-2483.
58. Luptak I, Yan J, Cui L, Jain M, Liao R and Tian R. Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress. Circulation 2007; 116:901-909.
59. Wessells RJ, Fitzgerald E, Cypser JR, Tatar M and Bodmer R. Insulin regulation of heart function in aging fruit flies. Nat Genet 2004; 36:1275-1281.
60. Longo VD. The Ras and Sch9 pathways regulate stress resistance and longevity. Exp Gerontol 2003; 38: p. 807-811.
61. Longo VD. Ras: the other pro-aging pathway. Sci Aging Knowledge Environ 2004; 2004:pe36.
62. Sebastiani P, Solovieff N, Puca A, Hartley SW, Melista E, Andersen S, Dworkis DA, Wilk JB, Myers RH, Steinberg MH, Montano M, Baldwin CT and Perls TT. Genetic Signatures of Exceptional Longevity in Humans. Science 2010: in press
63. Ingram DK and Reynolds MA. Assessing the predictive validity of psychomotor tests as measures of biological age in mice. Exp Aging Res 1986; 12:155-162.
64. Asensi M, Sastre J, Pallardo FV, Estrela JM and Vina J. Determination of oxidized glutathione in blood: highperformance liquid chromatography. Methods Enzymol 1994; 234: 367-371.
65. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN, Jr. and Sunderman FW, Jr. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehydethiobarbituric acid adduct. Clin Chem 1987; 33:214-220.
66. Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, Phelps ME and Weber WA. Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 2006; 47: 999-1006.
67. Hamacher K, Coenen HH and Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2- deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27:235-238.
68. Trygg J, Holmes E and Lundstedt T. Chemometrics in metabonomics. J Proteome Res 2007; 6:469-479.